Doctor profile · Federal record
Dr. Mark Sprenkle, MD
Pulmonary Disease Physician (CMS: Critical Care (Intensivists)) · Minneapolis, MN
- NPI 1396788782
- Accepts Medicare
- MIPS 82.5 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
715 S 8Th St
Minneapolis, MN 554041210
(612) 873-6963 - Additional location
-
701 Park Ave
Minneapolis, MN 554151623
(612) 873-3000
fax (612) 904-4675 - Mailing address
-
701 Park Ave
Minneapolis, MN 554151623
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- February 28, 2024
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Minnesota #43662
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396788782. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
237
Distinct HCPCS
6
Medicare allowed
$27,981
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 85 | 43 | $206 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 67 | 38 | $77 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 33 | 24 | $94 | |
94010 |
Test to measure expiratory airflow and volume | 26 | 23 | $8 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 15 | 15 | $129 | |
94729 |
Test to examine how well the lungs exchange gases | 11 | 11 | $9 |
In context: peer comparison
Among 18 peers in Minneapolis Pulmonary Disease Physician, average services per provider: 57. This provider delivers 4.2× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
601
Patients
90
Total drug cost
$204,732
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 98 | 31 | $4,512 |
| Prednisone | Generic | 89 | 28 | $791 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 74 | 15 | $59,273 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 42 | 16 | $2,666 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 41 | 0 | $19,855 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 35 | 0 | $13,913 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 31 | 0 | $20,183 |
| Spiriva Handihaler (Tiotropium Bromide) | Brand | 30 | 0 | $19,762 |
| Fluticasone Propionate | Generic | 28 | 0 | $406 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 26 | 0 | $11,714 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Sprenkle's medical specialty?
Dr. Mark Sprenkle practices Pulmonary Disease Physician in Minneapolis, MN.
Where does Dr. Mark Sprenkle practice?
Dr. Mark Sprenkle practices at 715 S 8Th St, Minneapolis, MN 554041210. Office phone: 6128736963.
What is Dr. Mark Sprenkle's NPI?
Dr. Mark Sprenkle's National Provider Identifier (NPI) is 1396788782, issued by NPPES.
Does Dr. Mark Sprenkle accept Medicare assignment?
Yes. Dr. Mark Sprenkle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Sprenkle commonly perform?
Top Medicare-reported procedures in 2023: Critical care (HCPCS 99291); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.